Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safe Step Act
Client: HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) · Firm: COVINGTON & BURLING LLP
Drug pricing policies, including H.R. 2163, The Safe Step Act.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, PDUFA reauthorization, H.R. 6; innovation issues; mental health legislation.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2022 · fourth_quarter · Q4
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2022 · fourth_quarter · Q4
Source: Senate LDA
| 2016–2022 |
| QUALCOMM INCORPORATED | 25 | 2005–2012 |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 21 | 1999–2008 |
| MEDICAID RECOVERY COALITION | 14 | 2008–2011 |
| NATIONAL GENERAL INSURANCE | 14 | 2017–2020 |
| PMX INDUSTRIES INC | 13 | 2007–2010 |
| VALNEVA USA, INC | 10 | 2021–2022 |
| AMERICAN ASSN OF ORAL & MAXILLOFACIAL SURGEONS | 8 | 1999–2003 |
| PUBLIC BROADCASTING SERVICE | 8 | 1999–2008 |
| LOUISIANA DEPARTMENT OF HEALTH AND HOSPITALS, RESEARCH AND DEVELOPMENT | 6 | 2009–2010 |
| METRO HEALTH HOSPITAL | 6 | 2008–2009 |
| ALCATEL-LUCENT USA, INC. | 5 | 2005–2007 |
| Amarin Pharma, Inc. | 5 | 2013–2014 |
| MICROSOFT CORP | 5 | 2001–2004 |
| 1776 PHARMACEUTICALS LLC | 4 | 2020–2021 |
| ABBOTT LABORATORIES | 4 | 2015 |
| AVANTIS MEDICAL SYSTEMS | 4 | 2010 |
| CALIFORNIA HEALTH AND HUMAN SERVICES AGENCY | 4 | 2017 |
| MONSTER ENERGY COMPANY | 4 | 2015 |
| ACCREDITATION COUNCIL FOR GRADUATE MEDICAL EDUCATION | 3 | 2015–2018 |
| ACS STATE & LOCAL SOLUTIONS | 3 | 2002 |
| BACARDI NORTH AMERICA CORPORATION | 3 | 2016 |
| CITRIX SYSTEMS INC | 3 | 2008–2009 |
| COPIAT | 3 | 1999–2000 |
| KOS PHARMACEUTICALS | 3 | 2005–2006 |
| STATE OF MISSOURI DEPT OF SOCIAL SERVICES | 3 | 1999–2000 |
| KBR GOVERNMENT OPERATIONS | 2 | 2006–2007 |
| LARGE SCALE BIOLOGY CORP | 2 | 2002 |
| METROPOLITAN LIFE INSURANCE CO | 2 | 2002 |
| WASHINGTON POST COMPANY | 2 | 1999–2000 |
| WESTVACO | 2 | 2000–2002 |
| AMERICAN WATCH ASSOCIATION | 1 | 2000 |
| ATTORNEYS' LIABILITY ASSURANCE SOCIETY INC | 1 | 2000 |
| BUSINESS ROUNDTABLE | 1 | 2000 |
| GTE CORP | 1 | 2000 |
| KOHLBERG KRAVIS ROBERTS & CO L P | 1 | 2007 |
| LAND TRUST ALLIANCE | 1 | 2000 |
| PARTNERS HEALTHCARESYSTEM | 1 | 2002 |
| TPG CAPITAL LP | 1 | 2007 |
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6; innovation issues; mental health legislation.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6; innovation issues; mental health legislation.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6; innovation issues; mental health legislation.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6; innovation issues; mental health legislation.
H.R. 6, 21st Century Cures Act.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6.
21st Century Cures Act
Client: SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) · Firm: COVINGTON & BURLING LLP
Medicare reimbursement of prescription drugs; 21st Century Cures Act, H.R. 6; innovation issues; mental health legislation.
H.R. 6, 21st Century Cures Act.
H.R. 6, 21st Century Cures Act.
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S. 515 H.R. 1260
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
Patent Reform generally S.1145 H.R. 1908
* ITC Decision regarding Qualcomm/Broadcom Patent Reform generally S. 1145 H.R. 1908 Patent Reform generally S. 1145 H.R. 1908
* ITC Decision regarding Qualcomm/Broadcom Patent Reform generally S. 1145 H.R. 1908 Patent Reform generally S. 1145 H.R. 1908
* Patent Reform Legislation S. 1145 H.R. 1908 ITC Decision regarding Qualcomm/Broadcom
* ITC Decision regarding Qualcomm/Broadcom Patent Reform generally S. 1145 H.R. 1908 Patent Reform generally S. 1145 H.R. 1908
* Patent Reform Legislation S. 1145 H.R. 1908 ITC Decision regarding Qualcomm/Broadcom
* ITC Decision regarding Qualcomm/Broadcom Patent Reform generally S. 1145 H.R. 1908 Patent Reform generally S. 1145 H.R. 1908
Retirement; long term care insurance.
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2022 · fourth_quarter · Q4
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2022 · fourth_quarter · Q4
Drug pricing policies, including H.R. 2163, The Safe Step Act.
Filing targets: HOUSE OF REPRESENTATIVES
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2022 · third_quarter · Q3
Drug pricing policies.
Filing targets: HOUSE OF REPRESENTATIVES
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2022 · third_quarter · Q3
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2022 · third_quarter · Q3
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2022 · third_quarter · Q3
Retirement; long term care insurance.
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Retirement; long term care insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2022 · second_quarter · Q2
Drug pricing policies.
340B policy.
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2022 · first_quarter · Q1
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2022 · first_quarter · Q1
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2022 · first_quarter · Q1
Retirement; long term care insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2022 · first_quarter · Q1
340B policy.
Drug pricing policies.
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2021 · first_quarter · RA
Coverage of CDC recommended vaccines.
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Drug pricing policies.
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2021 · fourth_quarter · Q4
Retirement; long term care insurance.
Filing targets: SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2021 · fourth_quarter · 4T
Pensions.
Cybersecurity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2021 · third_quarter · Q3
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2021 · third_quarter · Q3
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2021 · third_quarter · Q3
Retirement; long term care insurance.
Filing targets: HOUSE OF REPRESENTATIVES, Pension Benefit Guaranty Corporation (PBGC), SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2021 · third_quarter · Q3
Drug pricing policies.
UNISYS CORPORATION via COVINGTON & BURLING LLP
2021 · third_quarter · Q3
Pensions.
Cybersecurity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2021 · second_quarter · Q2
Coverage of CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2021 · second_quarter · Q2
Medicare reimbursement issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2021 · second_quarter · Q2
Retirement; long term care insurance.
Filing targets: HOUSE OF REPRESENTATIVES
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2021 · second_quarter · Q2
Drug pricing policies.
UNISYS CORPORATION via COVINGTON & BURLING LLP
2021 · second_quarter · Q2
Cybersecurity issues.
Pensions.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
CDC recommended vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
Drug pricing reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
Medicare drug pricing policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
Incentives related to life insurance.
Retirement security reform.
Filing targets: HOUSE OF REPRESENTATIVES
UNISYS CORPORATION via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
Single employer pension reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1776 PHARMACEUTICALS LLC via COVINGTON & BURLING LLP
2021 · first_quarter · Q1
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VALNEVA USA, INC. via COVINGTON & BURLING LLP
2021 · first_quarter · RR
Coverage of CDC recommended vaccines.
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
Medicare drug pricing reform.
UNISYS CORPORATION via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
Retirement security and cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
Retirement Security.
Tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1776 PHARMACEUTICALS LLC via COVINGTON & BURLING LLP
2020 · fourth_quarter · Q4
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Retirement security and cybersecurity.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Tax issues.
Retirement Security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Medicare drug pricing reform.
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1776 PHARMACEUTICALS LLC via COVINGTON & BURLING LLP
2020 · third_quarter · Q3
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
1776 PHARMACEUTICALS LLC via COVINGTON & BURLING LLP
2020 · third_quarter · RR
Re-shoring production of essential medicine
Re-shoring production of essential medicine
Re-shoring production of essential medicine
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Tax issues.
Retirement Security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Medicare coverage of home infusion drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2020 · second_quarter · Q2
Retirement, data privacy and cybersecurity issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Medicare coverage of home infusion drugs.
Filing targets: HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Retirement security and data protection.
Filing targets: SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2020 · first_quarter · Q1
Retirement Security and long term care insurance.
Tax issues.
Filing targets: HOUSE OF REPRESENTATIVES
UNISYS CORPORATION via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Retirement security and data protection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Tax issues.
Retirement Security and long term care insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Medicare reimbursement issue; orphan drug program.
Filing targets: HOUSE OF REPRESENTATIVES
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2019 · fourth_quarter · Q4
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
Medicare reimbursement issue; orphan drug program.
UNISYS CORPORATION via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
Retirement security and data protection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
Retirement Security and long term care insurance.
Tax issues.
Filing targets: HOUSE OF REPRESENTATIVES
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2019 · third_quarter · Q3
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2019 · first_quarter · Q1
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
Budget and appropriations.
Retirement security and data protection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
Medicare reimbursement issue; orphan drug program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2019 · second_quarter · Q2
Tax issues.
Retirement Security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2019 · first_quarter · RA
Medical Loss Ratio calculation.
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2019 · first_quarter · Q1
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2019 · first_quarter · Q1
Retirement Security.
Tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2019 · first_quarter · Q1
Medicare reimbursement issue; orphan drug program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2019 · first_quarter · Q1
Budget and appropriations.
Retirement security and data protection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Retirement security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Medicare reimbursement issue; 340B reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Budget and appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2018 · fourth_quarter · Q4
Medicare reimbursement of prescription drugs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
Medicare reimbursement of prescription drugs.
Drug innovation issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
Medicare reimbursement issue; 340B reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
Pension reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2018 · third_quarter · Q3
Retirement security.
Issues related to tax reform.
Reforms regarding ACA marketplace exchanges.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Budget and tax policy.
Pension reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Medicare reimbursement issue; 340B reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Medicare reimbursement of prescription drugs; mental health legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2018 · second_quarter · Q2
Retirement security.
Reforms regarding ACA marketplace exchanges.
Issues related to tax reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HORIZON THERAPEUTICS USA, INC. (FORMERLY HORIZON PHARMA USA, INC.) via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Medicare reimbursement issue; 340B reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL GENERAL INSURANCE via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Medical Loss Ratio calculation.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SUNOVION PHARMACEUTICALS, INC. (FORMERLY KNOWN AS SEPRACOR INC.) via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Medicare reimbursement of prescription drugs; mental health legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JOHN HANCOCK LIFE INSURANCE COMPANY (USA) (FKA JOHN HANCOCK FIN. SERVICES, INC.) via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Retirement security.
Issues related to tax reform.
Reforms regarding ACA marketplace exchanges.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNISYS CORPORATION via COVINGTON & BURLING LLP
2018 · first_quarter · Q1
Pension reform.
Budget and tax policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE